Retrospective Analysis of Chinese Chronic Myeloid Leukemia Patients Who Have Stopped Tyrosine Kinase Inhibitors

被引：0
|
作者：
Zhu, Xiaojian [1 ]
You, Yong [2 ]
Zhang, Yicheng [1 ]
Duan, Minghui [3 ,4 ]
Zhu, Yu [5 ]
Liu, Bingcheng [4 ,6 ]
Du, Xin [7 ]
Chen, Suning [8 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Hematol, Wuhan, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Hematol, Wuhan, Hubei, Peoples R China
[3] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Hematol, Beijing, Peoples R China
[4] Peking Union Med Coll, Beijing, Peoples R China
[5] Nanjing Med Univ, Jiangsu Prov Peoples Hosp Nanjing, Collaborat Innovat Ctr Canc Personalize, Affiliated Hosp 1,Key Lab Hematol, Nanjing, Jiangsu, Peoples R China
[6] Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, Leukemia Ctr, Tianjin, Peoples R China
[7] Shenzhen Univ, Shenzhen Second Peoples Hosp, Shenzhen Bone Marrow Transplantat Publ Serv Platf, Shenzhen Inst Hematol,Affiliated Hosp 1, Shenzhen, Peoples R China
[8] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-113854
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5443
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Monitoring and Analysis of Chinese Chronic Myeloid Leukemia Patients Who Have Stopped Tyrosine Kinase Inhibitor Therapy
    Shen, Na
    You, Yong
    Zhong, Zhao-dong
    Meng, Li
    Zhou, Jian-feng
    Zou, Ping
    Zhu, Xiao-jian
    Wang, Hong-xiang
    Cheng, Fan-jun
    CURRENT MEDICAL SCIENCE, 2019, 39 (02) : 211 - 216
  • [2] Monitoring and Analysis of Chinese Chronic Myeloid Leukemia Patients Who Have Stopped Tyrosine Kinase Inhibitor Therapy
    Na Shen
    Yong You
    Zhao-dong Zhong
    Li Meng
    Jian-feng Zhou
    Ping Zou
    Xiao-jian Zhu
    Hong-xiang Wang
    Fan-jun Cheng
    Current Medical Science, 2019, 39 : 211 - 216
  • [3] TYROSINE KINASE INHIBITORS DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS OF 208 ITALIAN PATIENTS
    Fava, C.
    Rege-Cambrin, G.
    Dogliotti, I.
    Berchialla, P.
    Abruzzese, E.
    Annunziata, M.
    Avanzini, P.
    Bergamaschi, M.
    Bocchia, M.
    Caocci, G.
    Catania, G.
    Cattaneo, D.
    Cavazzini, F.
    Cerrano, M.
    Chiara, E.
    Crugnola, M.
    Galimberti, S.
    Gambacorti-Passerini, C.
    Iuliano, F.
    Iurlo, A.
    Levato, L.
    Luciano, L.
    Musto, P.
    Orlandi, E.
    Pregno, P.
    Rapezzi, D.
    Russo, S.
    Santoro, M.
    Sora, F.
    Baccarani, M.
    Ferrero, D.
    Saglio, G.
    HAEMATOLOGICA, 2016, 101 : 64 - 64
  • [4] TYROSINE KINASE INHIBITORS DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS OF 208 ITALIAN PATIENTS
    Fava, C.
    Rege-Cambrin, G.
    Dogliotti, I.
    Berchialla, P.
    Cerrano, M.
    Rosti, G.
    Castagnetti, F.
    Gugliotta, G.
    Martino, B.
    Gambacorti-Passerini, C.
    Abruzzese, E.
    Orlandi, E.
    Chiara, E.
    Pregno, P.
    Gozzini, A.
    Avanzini, P.
    Bergamaschi, M.
    Crugnola, M.
    Bocchia, M.
    Galimberti, S.
    Rapezzi, D.
    Iurlo, A.
    Cattaneo, D.
    Latagliata, R.
    Breccia, M.
    Cedrone, M.
    Santoro, M.
    Annunziata, M.
    Levato, L.
    Stagno, F.
    Cavazzini, F.
    Sgherza, N.
    Catania, G.
    Luciano, L.
    Russo, S.
    Musto, P.
    Caocci, G.
    Sora, F.
    Iuliano, F.
    Lunghi, F.
    Specchia, G.
    Baccarani, M.
    Ferrero, D.
    Saglio, G.
    HAEMATOLOGICA, 2017, 102 : 84 - 84
  • [5] Retrospective Analysis of Allogeneic Transplant Outcomes in Chronic Myeloid Leukemia Patients with Tyrosine Kinase Inhibitors Failure
    Kim, Dennis Dong Hwan
    Bence-Bruckler, Isabelle
    Hillis, Christopher M.
    Walker, Irwin
    Kamel-Reid, Suzanne
    Lipton, Jeffrey H.
    BLOOD, 2014, 124 (21)
  • [6] WHO 2016 Definition of Chronic Myeloid Leukemia and Tyrosine Kinase Inhibitors
    Haznedaroglu, Ibrahim C.
    Kuzu, Isinsu
    Ilhan, Osman
    TURKISH JOURNAL OF HEMATOLOGY, 2020, 37 (01) : 42 - 47
  • [7] Smoking influences the outcomes of patients receiving tyrosine kinase inhibitors for chronic myeloid leukemia in the chronic phase: A retrospective analysis
    Iriyama, Noriyoshi
    Tokuhira, Michihide
    Sato, Eriko
    Sugimoto, Kei-Ji
    Takaku, Tomoiku
    Ishikawa, Maho
    Nakazato, Tomonori
    Fujita, Hiroyuki
    Kimura, Yuta
    Fujioka, Isao
    Asou, Norio
    Komatsu, Norio
    Kizaki, Masahiro
    Hatta, Yoshihiro
    Kawaguchi, Tatsuya
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (03) : 323 - 325
  • [8] Tyrosine kinase inhibitors in chronic myeloid leukemia
    Sawyers, CL
    Druker, B
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1999, 5 (02): : 63 - 69
  • [9] Effectiveness of Bosutinib in Chronic Myeloid Leukemia (CML) Who Have Received Multi Tyrosine Kinase Inhibitors (TKIs)
    Cortes, Jorge
    Kantarjian, Hagop M.
    Richard-Carpentier, Guillaume
    Borthakur, Gautam M.
    Ravandi, Farhad
    Naqvi, Kiran
    Sasaki, Koji
    Kadia, Tapan M.
    Verstovsek, Srdan
    Garcia-Manero, Guillermo
    DiNardo, Courtney D.
    Pemmaraju, Naveen
    Daver, Naval G.
    Bose, Prithviraj
    Pierce, Sherry A.
    Dara, Samuel
    Jabbour, Elias
    Cortes, Jorge E.
    BLOOD, 2019, 134
  • [10] Prospective Biochemical Analysis of Chronic Myeloid Leukemia Patients in Response to Tyrosine Kinase Inhibitors
    Arsalan, Hafiz Muhammad
    Arif, Amina
    Khan, Muhammad Khalil Ahmad
    PAKISTAN JOURNAL OF ZOOLOGY, 2023, 55 (05) : 2103 - 2111
12345